The cytotoxic chemotherapy market is projected to grow from USD 24,628.0 million in 2026 to USD 39,358.8 million by 2036, at a CAGR of 4.8%. Alkylating agents will dominate with a 28.0% market share, while breast cancer will lead the applications segment with a 26.0% share.